Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets

[at noodls] – DEERFIELD, IL — (Marketwire) — 02/06/13 — Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Skyepharma has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) … more

View todays social media effects on HZNP

View the latest stocks trending across Twitter. Click to view dashboard

See who Horizon is hiring next, click here to view